CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue:
Total revenue	$ 836,549	$ 777,707
Cost of Revenue:
Cost of revenue	337,796	306,925
Gross profit	498,753	470,782
Expenses:
Sales and marketing	132,292	114,811
General and administrative	77,949	70,770
Research and development	40,168	37,579
Income from operations	248,344	247,622
Interest expense	(6,996)	(7,584)
Interest income	143	52
Income before provision for income taxes	241,491	240,090
Provision for income taxes	47,526	35,801
Net income	193,965	204,289
Less: Net income attributable to noncontrolling interest	0	32
Net income attributable to IDEXX Laboratories, Inc. stockholders	$ 193,965	$ 204,257
Earnings per Share:
Basic (in USD per share)	$ 2.30	$ 2.39
Diluted (in USD per share)	$ 2.27	$ 2.35
Weighted Average Shares Outstanding:
Basic (in shares)	84,410	85,530
Diluted (in shares)	85,564	86,917
Product revenue
Revenue:
Total revenue	$ 478,377	$ 454,348
Cost of Revenue:
Cost of revenue	162,071	147,270
Service revenue
Revenue:
Total revenue	358,172	323,359
Cost of Revenue:
Cost of revenue	$ 175,725	$ 159,655